• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Protecting our future: call for respiratory syncytial virus vaccine trial in infants.

作者信息

Riaz Rumaisa, Sumbal Anusha, Khan Afsheen, Haque Md Ariful

机构信息

Department of Internal Medicine, Dow University of Health Sciences, Karachi, Pakistan.

Department of Public Health, Atish Dipankar University of Science and Technology.

出版信息

Ann Med Surg (Lond). 2024 Jul 17;86(9):4960-4962. doi: 10.1097/MS9.0000000000002385. eCollection 2024 Sep.

DOI:10.1097/MS9.0000000000002385
PMID:39238990
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11374237/
Abstract
摘要

相似文献

1
Protecting our future: call for respiratory syncytial virus vaccine trial in infants.保护我们的未来：呼吁开展婴儿呼吸道合胞病毒疫苗试验。
Ann Med Surg (Lond). 2024 Jul 17;86(9):4960-4962. doi: 10.1097/MS9.0000000000002385. eCollection 2024 Sep.
2
Safety and Immunogenicity of an Investigational Respiratory Syncytial Virus Vaccine (RSVPreF3) in Mothers and Their Infants: A Phase 2 Randomized Trial.在母亲及其婴儿中进行的一种呼吸道合胞病毒疫苗（RSVPreF3）的安全性和免疫原性的 2 期随机试验。
J Infect Dis. 2023 Aug 11;228(3):299-310. doi: 10.1093/infdis/jiad024.
3
The impact of maternal RSV vaccine to protect infants in Gavi-supported countries: Estimates from two models.母亲 RSV 疫苗对 Gavi 支持国家婴儿保护的影响：两种模型的估计。
Vaccine. 2020 Jul 14;38(33):5139-5147. doi: 10.1016/j.vaccine.2020.06.036. Epub 2020 Jun 22.
4
Summary of the Vaccines and Related Biological Products Advisory Committee meeting held to consider evaluation of vaccine candidates for the prevention of respiratory syncytial virus disease in RSV-naïve infants.疫苗和相关生物制品咨询委员会会议摘要，会议旨在评估预防 RSV -naive 婴儿呼吸道合胞病毒病的候选疫苗。
Vaccine. 2020 Jan 10;38(2):101-106. doi: 10.1016/j.vaccine.2019.10.048. Epub 2019 Nov 6.
5
Use of the Pfizer Respiratory Syncytial Virus Vaccine During Pregnancy for the Prevention of Respiratory Syncytial Virus-Associated Lower Respiratory Tract Disease in Infants: Recommendations of the Advisory Committee on Immunization Practices - United States, 2023.《妊娠期使用辉瑞呼吸道合胞病毒疫苗预防婴儿呼吸道合胞病毒相关下呼吸道疾病：免疫实践咨询委员会建议-美国，2023 年》。
MMWR Morb Mortal Wkly Rep. 2023 Oct 13;72(41):1115-1122. doi: 10.15585/mmwr.mm7241e1.
6
Prefusion F Protein-Based Respiratory Syncytial Virus Immunization in Pregnancy.孕期融合前 F 蛋白为基础的呼吸道合胞病毒免疫接种。
N Engl J Med. 2022 Apr 28;386(17):1615-1626. doi: 10.1056/NEJMoa2106062.
7
Society for Maternal-Fetal Medicine Statement: Clinical considerations for the prevention of respiratory syncytial virus disease in infants.母胎医学学会声明：预防婴儿呼吸道合胞病毒病的临床注意事项。
Am J Obstet Gynecol. 2024 Feb;230(2):B41-B49. doi: 10.1016/j.ajog.2023.10.046. Epub 2023 Oct 30.
8
Efficacy and safety of vaccines to prevent respiratory syncytial virus infection in infants and older adults: A systematic review and meta-analysis.疫苗预防婴儿和老年人呼吸道合胞病毒感染的有效性和安全性：系统评价和荟萃分析。
Int J Infect Dis. 2024 Sep;146:107118. doi: 10.1016/j.ijid.2024.107118. Epub 2024 Jun 13.
9
Respiratory Syncytial Virus Maternal Vaccination in Infants below 6 Months of Age: Meta-Analysis of Safety, Immunogenicity, and Efficacy.6 月龄以下婴儿的呼吸道合胞病毒（RSV）母传疫苗接种：安全性、免疫原性和有效性的荟萃分析。
Neonatology. 2024;121(3):271-282. doi: 10.1159/000536031. Epub 2024 Jan 29.
10
Respiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscape.呼吸道合胞病毒预防近在咫尺：疫苗和单克隆抗体领域。
Lancet Infect Dis. 2023 Jan;23(1):e2-e21. doi: 10.1016/S1473-3099(22)00291-2. Epub 2022 Aug 8.

本文引用的文献

1
Success in vaccination programming through community health workers: a qualitative analysis of interviews and focus group discussions from Nepal, Senegal and Zambia.通过社区卫生工作者实现疫苗接种规划的成功：来自尼泊尔、塞内加尔和赞比亚的访谈和焦点小组讨论的定性分析。
BMJ Open. 2024 Apr 3;14(4):e079358. doi: 10.1136/bmjopen-2023-079358.
2
National Immunization Program Decision Making Using the CAPACITI Decision-Support Tool: User Feedback from Indonesia and Ethiopia.使用CAPACITI决策支持工具进行国家免疫规划决策：来自印度尼西亚和埃塞俄比亚的用户反馈
Vaccines (Basel). 2024 Mar 20;12(3):337. doi: 10.3390/vaccines12030337.
3
[Not Available].[无可用内容]。
Ugeskr Laeger. 2024 Mar 11;186(11). doi: 10.61409/V12230800.
4
Milestone in infant health: unveiling the RSV vaccine's shielding effect for newborns.婴儿健康的里程碑：揭示呼吸道合胞病毒疫苗对新生儿的保护作用。
Int J Surg. 2024 Mar 1;110(3):1836-1838. doi: 10.1097/JS9.0000000000001002.
5
Safety and Immunogenicity of a Revaccination With a Respiratory Syncytial Virus Prefusion F Vaccine in Older Adults: A Phase 2b Study.老年人用呼吸道合胞病毒预融合 F 疫苗进行再接种的安全性和免疫原性：一项 2b 期研究。
J Infect Dis. 2024 Feb 14;229(2):355-366. doi: 10.1093/infdis/jiad321.
6
Palivizumab Prophylaxis in Infants and Young Children at Increased Risk of Hospitalization for Respiratory Syncytial Virus Infection.帕利珠单抗预防高风险住院的婴幼儿呼吸道合胞病毒感染。
Pediatrics. 2023 Jul 1;152(1). doi: 10.1542/peds.2023-061803.
7
Respiratory Syncytial Virus Prefusion F Protein Vaccine in Older Adults.老年人呼吸道合胞病毒预融合F蛋白疫苗
N Engl J Med. 2023 Feb 16;388(7):595-608. doi: 10.1056/NEJMoa2209604.
8
mRNA vaccines as an armor to combat the infectious diseases.信使核糖核酸疫苗作为对抗传染病的一种手段。
Travel Med Infect Dis. 2023 Mar-Apr;52:102550. doi: 10.1016/j.tmaid.2023.102550. Epub 2023 Feb 10.
9
Palivizumab for preventing severe respiratory syncytial virus (RSV) infection in children.帕利珠单抗预防儿童严重呼吸道合胞病毒（RSV）感染。
Cochrane Database Syst Rev. 2021 Nov 16;11(11):CD013757. doi: 10.1002/14651858.CD013757.pub2.
10
Global Molecular Epidemiology of Respiratory Syncytial Virus from the 2017-2018 INFORM-RSV Study.2017-2018 年 INFORM-RSV 研究中呼吸道合胞病毒的全球分子流行病学。
J Clin Microbiol. 2020 Dec 17;59(1). doi: 10.1128/JCM.01828-20.